Rockefeller Capital Management L.P. Lexaria Bioscience Corp. Transaction History
Rockefeller Capital Management L.P.
- $47.9 Billion
- Q3 2025
A detailed history of Rockefeller Capital Management L.P. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 200 shares of LEXX stock, worth $212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$212% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LEXX
# of Institutions
26Shares Held
1.8MCall Options Held
0Put Options Held
0-
Invenomic Capital Management LP Boston, MA477KShares$505,8330.02% of portfolio
-
Murchinson Ltd. Toronto, A6420KShares$444,7650.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA259KShares$274,3440.0% of portfolio
-
Geode Capital Management, LLC Boston, MA175KShares$185,2650.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6140KShares$148,4130.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $6.31M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...